GlassScriptPhysician profile
Jennifer Tymon
NPI 1346735479
$882.32
in general payments reported to CMS, 2019-2025
11 companies · $95.10 in 2025
The $95.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $203 · 2023: $428 · 2024: $156 · 2025: $95.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $680.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $679.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $165.93 | 2023-2024 | Altis |
| Boston Scientific Corporation | $158.63 | 2022-2025 | Solyx Sis System |
| Arthrex, INC. | $146.63 | 2023 | Arthrex |
| Conmed Corporation | $117.67 | 2023 | Airseal |
| Astellas Pharma US INC | $80.30 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $59.03 | 2022 | |
| Urovant Sciences INC | $41.23 | 2022 | |
| Axonics, INC. | $36.73 | 2022-2024 | Axonics, Bulkamid |
| Abbvie INC. | $36.19 | 2022-2023 | Botox |
| Sumitomo Pharma America, INC. | $21.77 | 2024 | Gemtesa |
| Teleflex LLC | $18.21 | 2024 | Solesta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Tymon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.